BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 35269789)

  • 1. PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca
    Lee HJ; Lee DM; Seo MJ; Kang HC; Kwon SK; Choi KS
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
    He L; Yu C; Qin S; Zheng E; Liu X; Liu Y; Yu S; Liu Y; Dou X; Shang Z; Wang Y; Wang Y; Zhou X; Liu B; Zhong Y; Liu Z; Lu J; Sun L
    Mol Cell; 2023 Nov; 83(22):4000-4016.e6. PubMed ID: 37935198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma.
    Xiang Y; Jia M; Gao Y; Yang F; Wang T; Dai R; Wang M; Miao H
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):106. PubMed ID: 38538281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
    Banerjee S; Wei T; Wang J; Lee JJ; Gutierrez HL; Chapman O; Wiley SE; Mayfield JE; Tandon V; Juarez EF; Chavez L; Liang R; Sah RL; Costello C; Mesirov JP; de la Vega L; Cooper KL; Dixon JE; Xiao J; Lei X
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24881-24891. PubMed ID: 31754034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
    Song W; Li Z; Xia M; Xiao W
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf1 can be processed and activated in a proteasome-independent manner.
    Vangala JR; Sotzny F; Krüger E; Deshaies RJ; Radhakrishnan SK
    Curr Biol; 2016 Sep; 26(18):R834-R835. PubMed ID: 27676297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraptosis: a non-classical paradigm of cell death for cancer therapy.
    Xu CC; Lin YF; Huang MY; Zhang XL; Wang P; Huang MQ; Lu JJ
    Acta Pharmacol Sin; 2024 Feb; 45(2):223-237. PubMed ID: 37715003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting GDP-Dissociation Inhibitor Beta (GDI2) with a Benzo[
    Sun Y; Zheng H; Qian L; Liu Y; Zhu D; Xu Z; Chang W; Xu J; Wang L; Sun B; Gu L; Yuan H; Lou H
    JACS Au; 2023 Oct; 3(10):2749-2762. PubMed ID: 37885576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Paraptosis: a unique cell death mode for targeting cancer.
    Hanson S; Dharan A; V JP; Pal S; Nair BG; Kar R; Mishra N
    Front Pharmacol; 2023; 14():1274076. PubMed ID: 37745056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells.
    Seo MJ; Kim IY; Lee DM; Park YJ; Cho MY; Jin HJ; Choi KS
    Cell Death Dis; 2023 Jan; 14(1):42. PubMed ID: 36658130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraptosis: a unique cell death mode for targeting cancer.
    Hanson S; Dharan A; P V J; Pal S; Nair BG; Kar R; Mishra N
    Front Pharmacol; 2023; 14():1159409. PubMed ID: 37397502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation.
    Li GN; Zhao XJ; Wang Z; Luo MS; Shi SN; Yan DM; Li HY; Liu JH; Yang Y; Tan JH; Zhang ZY; Chen RQ; Lai HL; Huang XY; Zhou JF; Ma D; Fang Y; Gao QL
    Signal Transduct Target Ther; 2022 Sep; 7(1):317. PubMed ID: 36097006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Paraptosis by Cyclometalated Iridium Complex-Peptide Hybrids and CGP37157 via a Mitochondrial Ca
    Yokoi K; Yamaguchi K; Umezawa M; Tsuchiya K; Aoki S
    Biochemistry; 2022 Apr; 61(8):639-655. PubMed ID: 35363482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative chemoproteomics reveals anticancer mechanisms of silver(i) targeting the proteasome regulatory complex.
    Shao X; Xing F; Zhang Y; Lok CN; Che CM
    Chem Sci; 2024 Apr; 15(14):5349-5359. PubMed ID: 38577372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Expressions of
    Xiong YM; Zhou F; Zhou JW; Liu F; Zhou SQ; Li B; Liu ZJ; Qin Y
    Curr Genomics; 2023 Dec; 24(6):368-384. PubMed ID: 38327651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance.
    Chen JW; Chen S; Chen GQ
    Cancer Drug Resist; 2023; 6(4):729-747. PubMed ID: 38239395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.
    Lee DM; Kim IY; Lee HJ; Seo MJ; Cho MY; Lee HI; Yoon G; Ji JH; Park SS; Jeong SY; Choi EK; Choi YH; Yun CO; Yeo M; Kim E; Choi KS
    Cell Death Dis; 2024 Jan; 15(1):48. PubMed ID: 38218922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting paraptosis in cancer: opportunities and challenges.
    Chen F; Tang H; Cai X; Lin J; Xiang L; Kang R; Liu J; Tang D
    Cancer Gene Ther; 2024 Mar; 31(3):349-363. PubMed ID: 38177306
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.